Sign Up
Stories
Biden's $35 Insulin Price Cap
Share
Biopharma Innovations in Obesity and Mus...
Counterfeit Ozempic Pills Spark Hypoglyc...
Drug Giants Secure Market Supremacy
Anti-Obesity Meds' Impact on Allurion Pr...
Biden Administration's Medicare Drug Pri...
Biden administration asserts power to se...
Overview
API
President Biden pushes for a $35 price cap for insulin for Medicare recipients, but its impact is questioned due to existing lower prices and limited coverage.
Ask a question
How might the $35 insulin price cap influence the pharmaceutical industry and drug pricing strategies?
In what ways could this policy impact the public perception of healthcare accessibility and government involvement?
What alternative approaches could be considered to ensure affordable insulin access for all diabetic individuals?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage